MoneyWorks4Me

Neuland Laboratories - Quaterly Results

06 Aug 2026 Evaluate
The total revenue surged to Rs. 6415.77 millions, up 119.15% for the June 2026 quarter as against Rs. 2927.53 millions during the year-ago period.Net Profit for the quarter ended June 2026 zoomed to 975.01% from Rs. 137.08 millions to Rs. 1473.62  millions.Operating Profit saw a handsome growth to 2310.69 millions from 421.49 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6415.77 2927.53 119.15 6415.77 2927.53 119.15 20229.85 14768.37 36.98
Other Income 84.92 78.56 8.10 84.92 78.56 8.10 301.64 205.09 47.08
PBIDT 2310.69 421.49 448.22 2310.69 421.49 448.22 6034.09 3428.08 76.02
Interest 69.72 45.83 52.13 69.72 45.83 52.13 239.45 82.96 188.63
PBDT 2240.97 375.66 496.54 2240.97 375.66 496.54 5794.64 4109.16 41.02
Depreciation 265.61 201.87 31.57 265.61 201.87 31.57 917.30 655.42 39.96
PBT 1975.36 173.79 1036.64 1975.36 173.79 1036.64 4877.34 3453.74 41.22
TAX 501.74 36.71 1266.77 501.74 36.71 1266.77 1246.29 859.48 45.01
Deferred Tax -7.06 -6.96 1.44 -7.06 -6.96 1.44 -42.55 122.95 -134.61
PAT 1473.62 137.08 975.01 1473.62 137.08 975.01 3631.05 2594.26 39.96
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 36.02 14.40 150.15 36.02 14.40 150.15 29.83 23.21 28.50

Neuland Laboratories Share Price

22843.55 1343.60 (6.25%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: